Profil
Karl G.
Trass formerly worked at Gilead Sciences, Inc., as Director-Regulatory Affairs in 2003, Tularik, Inc., as Associate Director-Regulatory Affairs from 2000 to 2002, Sangamo Therapeutics, Inc., as Director-Regulatory Affairs, AbbVie, Inc., as Director-Global Product Strategy, Genentech, Inc., as Senior Manager-Regulatory Affairs, Syntex Corp., as Senior Associate-Regulatory Affairs, Neurobiological Technologies, Inc., as VP-Regulatory Affairs & Quality Assurance, Graybug Vision, Inc., as Vice President-Global Regulatory Affairs, Alkahest, Inc., as Vice President-Regulatory Affairs, Tobira Therapeutics, Inc., as Vice President-Regulatory Affairs, Limerick BioPharma, Inc., as Vice President-Regulatory Affairs, and Versartis, Inc., as Vice President-Global Regulatory Affairs.
Mr. Trass received his undergraduate degree from Indiana University.
Anciens postes connus de Karl G. Trass
| Sociétés | Poste | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Conseiller Juridique Général | 01/07/2003 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Conseiller Juridique Général | 01/12/2002 |
| ABBVIE INC. | Corporate Officer/Principal | - |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Conseiller Juridique Général | - |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Operates as a research and drug discovery company | Conseiller Juridique Général | - |
Formation de Karl G. Trass
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Neurobiological Technologies, Inc.
Neurobiological Technologies, Inc. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Graybug Vision, Inc.
Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Operates as a research and drug discovery company | Health Technology |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
















